Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
23.76
+0.05 (0.21%)
At close: Nov 18, 2025, 4:00 PM EST
24.05
+0.29 (1.22%)
After-hours: Nov 18, 2025, 6:46 PM EST

Caris Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22
6,704---
Enterprise Value
6,415---
Debt / Equity Ratio
0.89-1.53-11.041.08
Asset Turnover
-1.090.54-
Inventory Turnover
-5.244.48-
Quick Ratio
9.090.931.863.29
Current Ratio
9.931.302.553.77
Return on Equity (ROE)
---293.82%-
Return on Assets (ROA)
--42.48%-35.34%-
Return on Capital (ROIC)
--93.29%-55.45%-
Return on Capital Employed (ROCE)
-8.90%-144.20%-100.60%-54.40%
Buyback Yield / Dilution
-201.21%-1.59%-4.73%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q